KR20230072619A - Cosmetic composition comprising turmeric saccharification fermented extract - Google Patents
Cosmetic composition comprising turmeric saccharification fermented extract Download PDFInfo
- Publication number
- KR20230072619A KR20230072619A KR1020210159059A KR20210159059A KR20230072619A KR 20230072619 A KR20230072619 A KR 20230072619A KR 1020210159059 A KR1020210159059 A KR 1020210159059A KR 20210159059 A KR20210159059 A KR 20210159059A KR 20230072619 A KR20230072619 A KR 20230072619A
- Authority
- KR
- South Korea
- Prior art keywords
- turmeric
- cosmetic composition
- weight
- parts
- present
- Prior art date
Links
- 235000003373 curcuma longa Nutrition 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 235000003392 Curcuma domestica Nutrition 0.000 title claims description 30
- 235000013976 turmeric Nutrition 0.000 title claims description 30
- 244000008991 Curcuma longa Species 0.000 title claims 5
- 239000000284 extract Substances 0.000 title description 17
- 238000000855 fermentation Methods 0.000 claims abstract description 20
- 230000004151 fermentation Effects 0.000 claims abstract description 17
- 230000002087 whitening effect Effects 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000006210 lotion Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- -1 serum Substances 0.000 claims description 4
- 201000004624 Dermatitis Diseases 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 244000163122 Curcuma domestica Species 0.000 abstract description 29
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 24
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 19
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 16
- 229940098773 bovine serum albumin Drugs 0.000 description 14
- 239000000047 product Substances 0.000 description 10
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000207199 Citrus Species 0.000 description 4
- 241000675108 Citrus tangerina Species 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 229960000271 arbutin Drugs 0.000 description 4
- 235000020971 citrus fruits Nutrition 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000012754 curcumin Nutrition 0.000 description 3
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
- 229960003957 dexamethasone Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- NBWRJAOOMGASJP-UHFFFAOYSA-N 2-(3,5-diphenyl-1h-tetrazol-1-ium-2-yl)-4,5-dimethyl-1,3-thiazole;bromide Chemical compound [Br-].S1C(C)=C(C)N=C1N1N(C=2C=CC=CC=2)N=C(C=2C=CC=CC=2)[NH2+]1 NBWRJAOOMGASJP-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 238000009010 Bradford assay Methods 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229930153442 Curcuminoid Natural products 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000012152 bradford reagent Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000010832 independent-sample T-test Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- JIJQKFPGBBEJNF-KBPBESRZSA-N Curlone Natural products CC(C)=CC(=O)C[C@H](C)[C@@H]1CCC(=C)C=C1 JIJQKFPGBBEJNF-KBPBESRZSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 101800001751 Melanocyte-stimulating hormone alpha Proteins 0.000 description 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 1
- 101710200814 Melanotropin alpha Proteins 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 1
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- JIJQKFPGBBEJNF-UHFFFAOYSA-N curlone Chemical compound CC(C)=CC(=O)CC(C)C1CCC(=C)C=C1 JIJQKFPGBBEJNF-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229940070818 glycyrrhizate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036564 melanin content Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 1
- WHNFPRLDDSXQCL-UHFFFAOYSA-N α-melanotropin Chemical compound C=1N=CNC=1CC(C(=O)NC(CC=1C=CC=CC=1)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)NC(CCCCN)C(=O)N1C(CCC1)C(=O)NC(C(C)C)C(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(NC(=O)C(CO)NC(C)=O)CC1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 울금 당화발효물을 포함하는 화장료 조성물에 관한 것으로, 피부 미백 및 염증 개선에 유용할 수 있다.The present invention relates to a cosmetic composition comprising a saccharified fermentation product of turmeric, which may be useful for skin whitening and inflammation improvement.
울금(Curcuma longa L.)은 생강과 Zingiberaceae의 근경으로 phenol류 및 그 배당체, monoterpene 배당체, tannin, 기타 sucrose 등의 성분으로 항염증작용, 항알레르기작용, 항균작용, 중추억제, 위액분비억제, 진경작용 등이 보고되어 있다. 전통적으로 한방에서 울금은 혈액순환을 돕는 약재 중 하나로 사용되었으며, 혈에만 작용하는 것이 아니라 기를 잘 통하게 하는 효능이 있어 간과 담에 기가 막힌 증상을 치료하고 혈분에 들어가 혈분의 열을 내리고 어혈을 풀어주는 역할까지 하기 때문에 혈중의 기약이라고 알려져 있다. 울금의 주성분으로는 커큐미노이드(curcuminoid) 유도체와 정유가 보고되어 있으며, 커큐미노이드(curcuminoid) 유도체로는 디아릴헵탄(diarylheptane)인 커큐민(curcumin)과 관련 유도체, 커큐민(curcumin)의 C9 chain 유도체(curcumins I-III)등이 보고되어 있고, 정유로는 세스쿼터핀(sesquiterpene) 관련 유도체로 튜메론(Turmerone), 컬론(curlone), 커큐멘(curcumene) 등이 있는 것으로 보고되었다. Turmeric ( Curcuma longa L. ) is a rhizome of ginger and Zingiberaceae. It is a component of phenols and its glycosides, monoterpene glycosides, tannin, and other sucrose. actions have been reported. Traditionally, in oriental medicine, turmeric has been used as one of the medicinal materials that help blood circulation, and it does not only act on blood, but also has the effect of guiding well. It is known as a blood medicine because it even plays a role. Curcuminoid derivatives and essential oils have been reported as the main components of turmeric. Curcuminoid derivatives include diarylheptane, curcumin, related derivatives, and C9 chain of curcumin. Derivatives (curcumins I-III) have been reported, and as essential oils, sesquiterpene-related derivatives such as turmerone, curlone, and curcumene have been reported.
본 발명자는 울금의 당화발효물에서 항염증 및 미백 효능이 현저히 향상됨을 알아내고 본 발명을 완성하였다.The present inventors have completed the present invention by finding that anti-inflammatory and whitening effects are remarkably improved in saccharification fermentation of turmeric.
본 발명의 목적은 울금 당화발효물을 포함하는 피부 미백용 화장료 조성물을 제공하는 것이다.An object of the present invention is to provide a cosmetic composition for skin whitening comprising a saccharified fermentation product of turmeric.
본 발명의 다른 목적은 울금 당화발효물을 포함하는 피부 염증 예방 또는 개선용 화장료 조성물을 제공하는 것이다.Another object of the present invention is to provide a cosmetic composition for preventing or improving skin inflammation comprising a saccharified fermentation product of turmeric.
상기 목적을 달성하기 위하여,In order to achieve the above purpose,
본 발명은 울금 당화발효물을 포함하는 피부 미백용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for skin whitening comprising fermented saccharification of turmeric.
본 발명은 울금 당화발효물을 포함하는 피부 염증 예방 또는 개선용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for preventing or improving skin inflammation comprising a saccharified fermentation product of turmeric.
본 발명에 따른 울금 당화발효물은,The turmeric saccharified fermentation product according to the present invention,
25 내지 27 brix의 설탕물 2650 중량부 기준 울금 건조물 95-105 중량부를 혼합하는 단계(단계 1);Mixing 95-105 parts by weight of dried turmeric based on 2650 parts by weight of 25 to 27 brix sugar water (step 1);
용기에 담고 밀폐한 다음, 20 내지 30℃ 온도에서 3 내지 5주 동안 혐기성 발효하는 단계(단계 2); 및Putting it in a container, sealing it, and anaerobic fermentation at a temperature of 20 to 30 ° C. for 3 to 5 weeks (step 2); and
발효물의 액상을 취하는 단계(단계 3);를 포함하여 제조할 수 있다.It can be prepared including; taking the liquid phase of the fermentation product (step 3).
본 발명에 따른 울금 당화발효물은 피부 미백 및 염증 개선에 효과가 있다.The saccharified fermentation product of turmeric according to the present invention is effective in skin whitening and inflammation improvement.
도 1은 실시예 1에 따른 울금 당화발효물의 처리농도별 멜라닌 생성량을 측정한 그래프이다.
도 2는 실시예 1에 따른 울금 당화발효물의 처리농도별 NO 생성량을 측정한 그래프이다.1 is a graph measuring the amount of melanin produced by treatment concentration of the saccharification and fermentation of turmeric according to Example 1.
Figure 2 is a graph measuring the amount of NO production for each treatment concentration of the saccharification and fermentation of turmeric according to Example 1.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에서 '추출물'이란, 당업계에 공지된 추출 및 분리하는 방법을 사용하여 유효성분 원료로부터 추출물을 분리 및 수득한 것을 의미하며, 본 발명에서 정의된 추출물은 적절한 용매를 이용하여 상기의 방법으로 준비된 유효성분 원료를 그대로 또는 분쇄하여 추출한 것일 수 있다. 이때 추출물을 수득하기 위해 사용할 수 있는 적절한 용매로는 당업계에서 허용되는 용매라면 어느 것을 사용해도 무방하며, 물 또는 유기용매를 사용할 수 있다. 예를 들어, 물, 탄소수 1 내지 5의 알코올, 헥산, 클로로포름, 부틸렌 글리콜(Butylene glycol) 등의 추출용매를 단독으로 혹은 혼합하여 사용할 수 있으나, 이에 제한되지는 않는다.In the present invention, 'extract' refers to separating and obtaining an extract from active ingredient raw materials using an extraction and separation method known in the art, and the extract defined in the present invention is obtained by using an appropriate solvent as described above. It may be extracted by extracting the active ingredient raw material prepared as it is or by grinding. At this time, as an appropriate solvent that can be used to obtain the extract, any solvent acceptable in the art may be used, and water or an organic solvent may be used. For example, extraction solvents such as water, alcohol having 1 to 5 carbon atoms, hexane, chloroform, and butylene glycol may be used alone or in combination, but are not limited thereto.
추출 방법으로는 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법 등의 방법을 사용할 수 있다. 또한, 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. 본 발명의 추출물의 제조방법에는 제한이 없으며, 공지되어 있는 어떠한 방법도 이용될 수 있다.As an extraction method, methods such as hot water extraction, cold brew extraction, reflux cooling extraction, solvent extraction, steam distillation, ultrasonic extraction, elution, and compression may be used. In addition, the desired extract may be additionally subjected to a conventional fractionation process or may be purified using a conventional purification method. There is no limitation on the preparation method of the extract of the present invention, and any known method may be used.
예를 들면, 본 발명의 조성물에 포함되는 추출물은 상기한 용매 추출법으로 추출된 1차 추출물을, 원심분리, 여과, 농축후 동결 건조하여 냉장실에 보관하면서 그대로 사용할 수도 있고, 상기 1차 추출물을 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. 또한, 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층 크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography)등과 같은 다양한 크로마토그래피를 이용하여 추가로 정제된 분획을 얻을 수도 있다. For example, the extract included in the composition of the present invention may be used as it is while storing the primary extract extracted by the solvent extraction method described above, centrifuged, filtered, and concentrated, then lyophilized and stored in a refrigerator, or the primary extract may be used as it is under reduced pressure. It can be prepared in a powder state by further processes such as distillation and freeze drying or spray drying. In addition, a fraction further purified from the primary extract using various chromatography methods such as silica gel column chromatography, thin layer chromatography, and high performance liquid chromatography. can also be obtained.
따라서 본 발명에 있어서 추출물은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, in the present invention, the extract is a concept that includes all extracts, fractions, and purified products obtained in each step of extraction, fractionation, or purification, and dilutions, concentrates, or dried products thereof.
화장료 조성물cosmetic composition
본 발명은 유효물질을 포함하는 화장료 조성물을 제공한다.The present invention provides a cosmetic composition containing an active substance.
상기 화장료 조성물은, 예를 들면 용액, 겔, 고체 또는 반죽 무수 생성물, 수상에 유상을 분산시켜 얻은 에멀젼, 현탁액, 마이크로에멀젼, 마이크로캡슐, 미세과립구 또는 이온형(리포좀), 비이온형의 소낭 분산제의 형태일 수 있다. 더욱 구체적인 형태로는 화장수, 유액, 크림, 스킨, 로션, 세럼, 에센스, 에멀젼, 파우더, 화장연고, 스프레이, 젤, 팩, 클렌저, 비누, 샴푸, 린스, 입욕제, 세정제 또는 콘실 스틱의 형태로 제공될 수 있다. 또한, 폼(foam)의 형태 또는 압축된 추진제를 더 함유한 에어로졸 조성물의 형태로도 제조될 수 있다.The cosmetic composition is, for example, a solution, gel, solid or kneaded anhydrous product, emulsion obtained by dispersing an oil phase in an aqueous phase, suspension, microemulsion, microcapsule, microgranule or ionic (liposome), nonionic vesicle dispersant may be in the form of In more specific form, it is provided in the form of lotion, emulsion, cream, toner, lotion, serum, essence, emulsion, powder, cosmetic ointment, spray, gel, pack, cleanser, soap, shampoo, rinse, bath additive, cleanser, or conceal stick. It can be. In addition, it may be prepared in the form of a foam (foam) or the form of an aerosol composition further containing a compressed propellant.
또한, 상기 화장료 조성물은 본 발명의 유효물질에 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다.In addition, the cosmetic composition includes a fatty substance, an organic solvent, a solubilizing agent, a thickening agent and a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, a surfactant, Water, ionic or nonionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, humectants, essential oils, dyes, pigments, hydrophilic or lipophilic actives, lipid vesicles or commonly used in cosmetics It may contain adjuvants commonly used in the cosmetic field, such as any other ingredients that are
본 발명의 유효물질을 함유하는 화장료 조성물에 있어서, 통상적으로 함유되는 화장료 조성물에 본 발명의 유효물질이 0.1 내지 50 중량%, 바람직하게는 1 내지 10 중량%의 양으로 첨가될 수 있다.In the cosmetic composition containing the active material of the present invention, the active material of the present invention may be added in an amount of 0.1 to 50% by weight, preferably 1 to 10% by weight, in the cosmetic composition that is usually contained.
본 발명의 유효물질을 피부 외용제로 사용하는 경우, 추가로 지방 물질, 유기 용매, 용해제, 농축제 및 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉쇄제 및 킬레이트화제, 보존제, 비타민, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 지질 소낭 또는 피부용 외용제에 통상적으로 사용되는 임의의 다른 성분과 같은 피부 과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 또한, 상기 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다.When the active substance of the present invention is used as an external skin preparation, additionally, a fatty substance, an organic solvent, a solubilizing agent, a thickening agent and a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizer, a foaming agent, a fragrance, and a surfactant , water, ionic or nonionic emulsifiers, fillers, sequestering agents and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic or lipophilic actives, lipid vesicles, or external preparations for skin It may contain adjuvants commonly used in the field of dermatology, such as any other ingredients used as In addition, the components may be introduced in an amount generally used in the field of skin science.
또한, 상기 화장료 조성물은 본 발명에 따른 화장료 조성물은 세럼, 화장수, 에센스, 페이스트, 마스크팩, 패치, 겔, 크림, 로션, 영양로션, 영양크림, 수분크림, 마사지크림, 파우더, 비누, 클렌저, 오일, 파운데이션, 메이크업 베이스, 왁스, 스프레이 등의 제형으로 제조하여 사용할 수 있다.In addition, the cosmetic composition according to the present invention is a serum, lotion, essence, paste, mask pack, patch, gel, cream, lotion, nutrient lotion, nutrient cream, moisture cream, massage cream, powder, soap, cleanser, It can be prepared and used in formulations such as oil, foundation, makeup base, wax, and spray.
이하, 본 발명을 하기의 실시예에 의하여 더욱 상세하게 설명한다. 단, 하기의 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기의 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail by the following examples. However, the following examples are merely illustrative of the present invention, and the contents of the present invention are not limited by the following examples.
<실시예 1> 울금 당화발효물의 준비<Example 1> Preparation of fermented saccharification of turmeric
정제수 2L에 설탕 0.65kg을 첨가하여 대략 26 brix의 설탕물을 준비하고, 여기에 울금 건조물 100g을 첨가하고 밀폐한 다음, 대략 22 ℃ 온도를 유지하는 보관실에서 혐기성 발효를 4주 동안 진행하였다.Approximately 26 brix of sugar water was prepared by adding 0.65 kg of sugar to 2 L of purified water, and 100 g of dried turmeric was added thereto, sealed, and anaerobic fermentation was carried out for 4 weeks in a storage room maintaining a temperature of about 22 ° C.
4주간 발효를 진행한 다음 100 mesh 필터를 사용하여 발효물 액상 샘플을 얻었고, 이를 활성 평가에서 희석하여 사용하였다.After fermentation for 4 weeks, a liquid sample of the fermentation product was obtained using a 100 mesh filter, which was diluted and used in activity evaluation.
<실험예 1> 미백 활성 평가<Experimental Example 1> Evaluation of whitening activity
(1) 시험 재료(1) test material
마우스 멜로노마 세포 (Murine melanoma B16F10 Cells, ATCC, USA)Mouse melanoma B16F10 Cells (ATCC, USA)
DMEM (Dulbecco's Modified Eagle's Medium, Gibco, USA)DMEM (Dulbecco's Modified Eagle's Medium, Gibco, USA)
FBS (Fetal bovine serum, Gibco, USA)FBS (Fetal bovine serum, Gibco, USA)
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, Amresco, USA)MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, Amresco, USA)
Arbutin (Sigma, USA)Arbutin (Sigma, USA)
NaOH (Sigma, USA)NaOH (Sigma, USA)
PBS (Phosphate buffered saline, Gibco, USA)PBS (Phosphate buffered saline, Gibco, USA)
Melanin (Sigma, USA)Melanin (Sigma, USA)
(2) 세포내외의 멜라닌 양 측정 실험방법(2) Test method for measuring the amount of melanin inside and outside the cell
6-well plate에 B16F10 세포를 well당 1×105 cells/well 농도로 접종한 후 세포 배양 조건에서 24시간 배양한다. 이 후, 각 well의 배지를 제거하고 PBS로 세척한 다음, 페놀 레드 미함유 DMEM 배지에 각 농도별 시험물질(DMEM 배양 배지에 실시예 1의 샘플을 희석하여 사용하였음)과 α-Melanocyte stimulating hormone (α-MSH, 최종 처리 농도 100 nM)를 함유한 배지를 넣고 72시간 배양한다. 이 후, 세포외 멜라닌 양 측정을 위해 상층액을 취하여 배지 중 유리된 멜라닌을 400 nm 또는 490 nm에서 흡광도를 측정한다. 세포내 멜라닌 양 측정을 위해 배지를 제거한 후의 세포는 PBS 로 세척 후 1M NaOH로 60℃에서 30분간 용해하여 400nm 또는 490nm에서 흡광도를 측정한다. 배지 속 유리된 멜라닌 양과 세포 내 멜라닌 양을 합하여 총 멜라닌 양으로 하고, 총 멜라닌 양은 총 단백질 양으로 보정한다. 용매대조군은 시험물질 대신 페놀 레드 미함유 DMEM 배지를 사용하고, 양성대조군은 알부틴 100 ㎍/mL을 사용한다.B16F10 cells are inoculated into a 6-well plate at a concentration of 1×10 5 cells/well per well, and cultured for 24 hours under cell culture conditions. Thereafter, the medium of each well was removed, washed with PBS, and the test substance for each concentration (the sample of Example 1 was diluted and used in DMEM culture medium) and α-Melanocyte stimulating hormone in DMEM medium without phenol red (α-MSH,
단백질량은 표준용액으로 소혈청알부민(BSA)을 사용하여 Bradford 방법에 따라 정량한다. BSA는 0, 2, 5, 10, 20, 40 ㎍/mL로 증류수에 단계적으로 희석하고 1.5 mL 튜브에 0.98 mL의 Bradford 시약과 각 농도의 BSA 용액을 20 μL씩 넣고 5분간 반응시킨 후 96-well plate로 200 μL 옮겨 595 nm에서 흡광도를 측정하여 BSA standard curve를 구한다. 위와 동일한 방법으로 BSA 용액 대신 각 세포 용해액과 Nradford 시약 혼합액의 흡광도를 측정하고 BSA로부터 얻은 standard curve를 이용하여 단백질량을 산출한다.The amount of protein is quantified according to the Bradford method using bovine serum albumin (BSA) as a standard solution. BSA was diluted in distilled water to 0, 2, 5, 10, 20, and 40 μg/mL in stages, and 0.98 mL of Bradford reagent and 20 μL of each concentration of BSA solution were added to a 1.5 mL tube, reacted for 5 minutes, and then 96- Transfer 200 μL to a well plate and measure the absorbance at 595 nm to obtain the BSA standard curve. In the same way as above, measure the absorbance of each cell lysate and the Nradford reagent mixture instead of the BSA solution, and calculate the protein amount using the standard curve obtained from BSA.
모든 자료는 평균값±표준편차로 나타내었으며, 통계분석은 SPSS® Package Program (IBM, USA)을 사용하여 분석한다. 모든 결과는 3번 이상의 독립적인 실험 결과이며 통계적인 유의성은 independent samples t-test로 p<0.05 유의수준에서 검증한다.All data were expressed as mean value ± standard deviation, and statistical analysis was performed using SPSS ® Package Program (IBM, USA). All results are the results of three or more independent experiments, and statistical significance is verified at the significance level of p<0.05 by independent samples t-test.
(3) 실험결과(3) Experimental results
<실시예 1>saccharification curcuma longa
<Example 1>
상기 표 1의 결과를 도안화하여 도 1에 나타내었다.The results of Table 1 are illustrated and shown in FIG.
도 1은 실시예 1에 따른 울금 당화발효물의 처리농도별 멜라닌 생성량을 측정한 그래프이다.1 is a graph measuring the amount of melanin produced by treatment concentration of the saccharification and fermentation of turmeric according to Example 1.
표 1 및 도 1에 나타난 바와 같이, 당화 울금의 처리농도가 증가할수록 멜라닌 생성량은 감소하는 것을 확인할 수 있었다.As shown in Table 1 and FIG. 1, it was confirmed that the amount of melanin produced decreased as the treatment concentration of saccharified turmeric increased.
<실험예 2> 항염증 활성 평가<Experimental Example 2> Evaluation of anti-inflammatory activity
(1) 시험 재료(1) test material
마우스 대식세포 (RAW264.7 cells, ATCC, USA)Mouse macrophages (RAW264.7 cells, ATCC, USA)
DMEM (Dulbecco's Modified Eagle's Medium, Gibco, USA)DMEM (Dulbecco's Modified Eagle's Medium, Gibco, USA)
FBS (Fetal bovine serum, Gibco, USA)FBS (Fetal bovine serum, Gibco, USA)
PBS (Phosphate buffered saline, Gibco, USA)PBS (Phosphate buffered saline, Gibco, USA)
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, Amresco, USA)MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, Amresco, USA)
Nitric oxide [NO] detection kit (iNtRON, USA)Nitric oxide [NO] detection kit (iNtRON, USA)
Dexamethasone (Sigma-Aldrich, USA)Dexamethasone (Sigma-Aldrich, USA)
(2) NO 생성 억제 실험방법(2) NO production suppression test method
24-well plate에 RAW 264.7 세포를 10% FBS가 첨가된 DMEM 배지를 이용하여 1.8 × 105 cells/well 농도로 접종하고 16시간 배양한 후에 각 농도별 시험물질(DMEM 배양 배지에 실시예 1의 샘플을 희석하여 사용하였음)과 LPS 1 ㎍/mL를 동시에 처리하여 24시간 배양한다. 생성된 NO의 양은 Nitric oxide detection kit를 이용하여 세포 배양액 중에 존재하는 NO2 -를 측정한다. 96-well plate에 세포배양 상등액 100 μL와 N1 buffer (Substrate solution) 50 μL를 혼합하여 10분간 상온에서 반응시킨 후 N2 buffer 50 μL를 첨가하여 540 nm에서 흡광도를 측정한다. 측정된 NO 생성량은 총 단백질량으로 보정하며, 양성대조군으로는 Dexamethasone (최종 처리농도 7.8 μg/mL)을 이용하여 비교한다.RAW 264.7 cells were inoculated in a 24-well plate at a concentration of 1.8 × 10 5 cells/well using DMEM medium supplemented with 10% FBS, and after culturing for 16 hours, the test substances for each concentration (DMEM culture medium of Example 1) were inoculated. Samples were diluted and used) and 1 μg/mL of LPS were simultaneously treated and incubated for 24 hours. The amount of NO produced is measured by NO 2 - present in the cell culture medium using a Nitric oxide detection kit. In a 96-well plate, mix 100 μL of cell culture supernatant and 50 μL of N1 buffer (substrate solution), react at room temperature for 10 minutes, add 50 μL of N2 buffer, and measure absorbance at 540 nm. The measured NO production amount is corrected by the total protein amount, and as a positive control group, Dexamethasone (final treatment concentration 7.8 μg/mL) is used for comparison.
단백질량은 표준용액으로 소혈청알부민(BSA)을 사용하여 Bradford 방법에 따라 정량한다. BSA는 0, 2, 5, 10, 20, 40 ㎍/mL로 증류수에 단계적으로 희석하고 1.5 mL 튜브에 0.98 mL의 Bradford 시약과 각 농도의 BSA 용액을 20 μL씩 넣고 5분간 반응시킨 후 96-well plate로 200 μL 옮겨 595 nm에서 흡광도를 측정하여 BSA standard curve를 구한다. 위와 동일한 방법으로 BSA 용액 대신 각 세포 용해액과 Nradford 시약 혼합액의 흡광도를 측정하고 BSA로부터 얻은 standard curve를 이용하여 단백질량을 산출한다.The amount of protein is quantified according to the Bradford method using bovine serum albumin (BSA) as a standard solution. BSA was diluted in distilled water to 0, 2, 5, 10, 20, and 40 μg/mL in stages, and 0.98 mL of Bradford reagent and 20 μL of each concentration of BSA solution were added to a 1.5 mL tube, reacted for 5 minutes, and then 96- Transfer 200 μL to a well plate and measure the absorbance at 595 nm to obtain the BSA standard curve. In the same way as above, measure the absorbance of each cell lysate and the Nradford reagent mixture instead of the BSA solution, and calculate the protein amount using the standard curve obtained from BSA.
모든 자료는 평균값±표준편차로 나타내었으며, 통계분석은 SPSS® Package Program (IBM, USA)을 사용하여 분석한다. 모든 결과는 3번 이상의 독립적인 실험 결과이며 통계적인 유의성은 independent samples t-test로 p<0.05 유의수준에서 검증한다.All data were expressed as mean value ± standard deviation, and statistical analysis was performed using SPSS ® Package Program (IBM, USA). All results are the results of three or more independent experiments, and statistical significance is verified at the significance level of p<0.05 by independent samples t-test.
(3) 실험결과(3) Experimental results
<실시예 1>saccharification curcuma longa
<Example 1>
상기 표 2의 결과를 도안화하여 도 2에 나타내었다.The results of Table 2 are illustrated and shown in FIG. 2 .
도 2는 실시예 1에 따른 울금 당화발효물의 처리농도별 NO 생성량을 측정한 그래프이다.Figure 2 is a graph measuring the amount of NO production for each treatment concentration of the saccharification and fermentation of turmeric according to Example 1.
표 2 및 도 2에 나타난 바와 같이, 당화 울금의 처리농도가 증가할수록 NO 생성량은 감소하는 것을 확인할 수 있었다. 따라서, 당화 울금은 항염증 효능이 있음을 알 수 있었다.As shown in Table 2 and FIG. 2, it was confirmed that the amount of NO production decreased as the treatment concentration of saccharified turmeric increased. Therefore, it was found that saccharified turmeric has an anti-inflammatory effect.
화장료의 제제예Formulation example of cosmetics
본 발명에 따른 풋귤, 울금 및 감귤꽃꿀 추출물은 목적에 따라 여러 형태의 화장료로 제조 가능하다. 하기는 본 발명에 따른 풋귤, 울금 및 감귤꽃꿀 추출물을 활성성분으로 함유시킨 몇몇 화장료의 제조방법을 예시한 것으로 본 발명이 이에 한정되는 것은 아니다.The green tangerine, turmeric, and citrus flower honey extracts according to the present invention can be manufactured into various types of cosmetics depending on the purpose. The following exemplifies a method for preparing some cosmetics containing green tangerine, turmeric, and citrus flower honey extract as an active ingredient, but the present invention is not limited thereto.
<제제예 1> 유연 화장수의 제조<Formulation Example 1> Preparation of softening lotion
풋귤, 울금 및 감귤꽃꿀 추출물 10.0 중량부Green tangerine, turmeric and citrus flower honey extract 10.0 parts by weight
1,3-부틸렌글리콜 1.00 중량부1,3-butylene glycol 1.00 parts by weight
디소듐이디티에이 0.05 중량부Disodium EDT 0.05 part by weight
알란토인 0.10 중량부allantoin 0.10 parts by weight
디포타슘글리시리제이트 0.05 중량부dipotassium glycyrrhizate 0.05 parts by weight
시트르산 0.01 중량부citric acid 0.01 part by weight
소듐시트레이트 0.02 중량부sodium citrate 0.02 part by weight
글리세레스-26 1.00 중량부glycereth-26 1.00 parts by weight
알부틴 2.00 중량부Arbutin 2.00 parts by weight
하이드로제네이티드캐스터오일 1.00 중량부Hydrogenated Castor Oil 1.00 parts by weight
에탄올 30.0 중량부ethanol 30.0 parts by weight
보존제 미량preservative a very small amount
착색제 미량coloring agent a very small amount
착향제 미량flavoring agent a very small amount
정제수 잔량Purified water balance
<제제예 2> 영양 크림의 제조<Formulation Example 2> Preparation of nutrient cream
풋귤, 울금 및 감귤꽃꿀 추출물 10.0 중량부Green tangerine, turmeric and citrus flower honey extract 10.0 parts by weight
1,3-부틸렌글리콜 7.00 중량부1,3-butylene glycol 7.00 parts by weight
글리세린 1.00 중량부glycerin 1.00 parts by weight
D-판테놀 0.10 중량부D-panthenol 0.10 part by weight
식물 추출물 3.20 중량부plant extract 3.20 parts by weight
마그네슘알루미늄실리케이트 0.30 중량부Magnesium aluminum silicate 0.30 part by weight
PEG-40 스테아레이트 1.20 중량부PEG-40 Stearate 1.20 parts by weight
스테아르산 2.00 중량부stearic acid 2.00 parts by weight
폴리소르베이트 60 1.50 중량부polysorbate 60 1.50 parts by weight
친유형글리세릴스테아레이트 2.00 중량부Lipophilic Glyceryl Stearate 2.00 parts by weight
소르비탄세스퀴올리에이트 1.50 중량부Sorbitan sesquioleate 1.50 parts by weight
세테아릴알코올 3.00 중량부Cetearyl Alcohol 3.00 parts by weight
미네랄오일 4.00 중량부mineral oil 4.00 parts by weight
스쿠알란 3.80 중량부squalane 3.80 parts by weight
카르릴릭/카프릭트리글리세라이드 2.80 중량부Carrylic/capric triglycerides 2.80 parts by weight
식물성오일 1.80 중량부vegetable oil 1.80 parts by weight
디메치콘 0.40 중량부dimethicone 0.40 parts by weight
디포슘글리시리제이트 미량Diposium glycyrrhizate a very small amount
알란토인 미량allantoin a very small amount
소듐 히아루로네이트 미량sodium hyaluronate a very small amount
토코페릴아세테이트 적량Tocopheryl Acetate Appropriate amount
트리에탄올아민 적량triethanolamine Appropriate amount
보존제 적량preservative Appropriate amount
착향제 적량flavoring agent Appropriate amount
정제수 잔량Purified water balance
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특히 청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far, the present invention has been looked at with respect to its preferred embodiments. Those skilled in the art to which the present invention pertains will be able to understand that the present invention can be implemented in a modified form without departing from the essential characteristics of the present invention. Therefore, the disclosed embodiments should be considered from an illustrative rather than a limiting point of view. The scope of the present invention is shown in particular in the claims rather than the foregoing description, and all differences within the equivalent range will be construed as being included in the present invention.
Claims (4)
A cosmetic composition for skin whitening comprising fermented saccharification of turmeric.
A cosmetic composition for preventing or improving skin inflammation comprising a saccharified fermentation product of turmeric.
상기 울금 당화발효물은,
25 내지 27 brix의 설탕물 2650 중량부 기준 울금 건조물 95-105 중량부를 혼합하는 단계(단계 1);
용기에 담고 밀폐한 다음, 20 내지 30℃ 온도에서 3 내지 5주 동안 혐기성 발효하는 단계(단계 2); 및
발효물의 액상을 취하는 단계(단계 3);를 포함하여 제조하는 것을 특징으로 하는 화장료 조성물.
According to claim 1 or 2,
The turmeric saccharified fermentation product,
Mixing 95-105 parts by weight of dried turmeric based on 2650 parts by weight of 25 to 27 brix sugar water (step 1);
Putting it in a container, sealing it, and anaerobic fermentation at a temperature of 20 to 30 ° C. for 3 to 5 weeks (step 2); and
A cosmetic composition comprising the step of taking the liquid phase of the fermented product (step 3).
화장수, 유액, 크림, 스킨, 로션, 세럼, 에센스, 에멀젼, 파우더, 화장연고, 스프레이, 젤, 팩, 클렌저, 비누, 샴푸, 린스, 입욕제, 세정제 및 콘실 스틱으로 이루어진 군에서 선택되는 어느 하나의 제형으로 제조된 것을 특징으로 하는, 화장료 조성물.According to claim 1 or 2,
Any one selected from the group consisting of lotion, emulsion, cream, toner, lotion, serum, essence, emulsion, powder, cosmetic ointment, spray, gel, pack, cleanser, soap, shampoo, rinse, bath additive, cleanser, and conceal stick Characterized in that prepared in a formulation, a cosmetic composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210159059A KR20230072619A (en) | 2021-11-18 | 2021-11-18 | Cosmetic composition comprising turmeric saccharification fermented extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210159059A KR20230072619A (en) | 2021-11-18 | 2021-11-18 | Cosmetic composition comprising turmeric saccharification fermented extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230072619A true KR20230072619A (en) | 2023-05-25 |
Family
ID=86541790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210159059A KR20230072619A (en) | 2021-11-18 | 2021-11-18 | Cosmetic composition comprising turmeric saccharification fermented extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230072619A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190001163A (en) | 2017-06-26 | 2019-01-04 | 목포대학교산학협력단 | Anti-inflammatory agent containing fermented curcuma longa |
-
2021
- 2021-11-18 KR KR1020210159059A patent/KR20230072619A/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190001163A (en) | 2017-06-26 | 2019-01-04 | 목포대학교산학협력단 | Anti-inflammatory agent containing fermented curcuma longa |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101352363B1 (en) | Composition of skin external application for moisturizing comprising Scrophularia buergeriana Miq. extract | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
JP2001288066A (en) | Skin barrier function ameliorator | |
JP5616045B2 (en) | Ceramide production promoter and moisturizer | |
KR101827771B1 (en) | Cosmetic composition containing Broussonetia extract for improving acne | |
KR102006712B1 (en) | Cosmetic Compositions Containing Extract of Deer Antler | |
US20210113640A1 (en) | Composition for promoting hair growth or preventing hair loss containing extract of aster ageratoides | |
KR102241951B1 (en) | Composition for preventing, treating or improving prostate disease or alopecia comprising mixed extracts of Angelica gigas and Torilis japonica | |
JP2003160461A (en) | Skin care preparation | |
EP4285890A1 (en) | Methods for extracting compound from ginseng, ginseng extract comprising the compound and composition for enhancing skin barrier comprising the same | |
KR20170058901A (en) | Composition of skin external application for skin homeostasis containing ginseng berry extracts | |
KR101852510B1 (en) | Cosmetic Composition Containing Broussonetia Extract for Inhibiting Lipogenesis and Decreasing Sebum Secretion of Skin | |
KR100894714B1 (en) | Extract of humata tyermanni moore having skin whitening and anti-oxidative activation | |
CN109689026B (en) | Method for increasing lipolysis using a composition comprising a bioactive lotus extract | |
KR20230072619A (en) | Cosmetic composition comprising turmeric saccharification fermented extract | |
KR102008485B1 (en) | Cosmetic Composition for skin moisturizing comprising Aquilaria agallocha Roxburgh extracts | |
KR102455132B1 (en) | Cosmetic composition containing lemon myrtle extract and its manufacturing method | |
KR100532010B1 (en) | Cosmetic composition containing persicaria thunbergii and ixeris dentata extracts stabilized with nanoliposome | |
KR101050484B1 (en) | Skin whitening composition containing lactone compound as an active ingredient | |
KR20180102928A (en) | A cosmetic composition for skin antiaging comprising an extract of Citrusfortunella microcarpa as an active ingredient | |
KR101605517B1 (en) | Manufacturing method for cosmetic composition for improving acne and cosmetic compostion thereof | |
KR20180055137A (en) | Composition comprising Rhus Semialata extract as active ingredient | |
JP4197194B2 (en) | Oral administration agent for intercellular adhesion suppression | |
KR101763736B1 (en) | Composition for moisturizing skin containing extracts prepared by enzyme process | |
KR20150050980A (en) | Cosmetic composition and external composition comprising Withania somnifera for anti-inflammatory |